We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
Cap. Flow
+$1.81B
Cap. Flow %
9.28%
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$694M
2
PM icon
Philip Morris
PM
+$316M
3
JNJ icon
Johnson & Johnson
JNJ
+$315M
4
MRK icon
Merck
MRK
+$303M
5
APC
Anadarko Petroleum
APC
+$235M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$248M
2
MU icon
Micron Technology
MU
+$212M
3
RAD
Rite Aid Corporation
RAD
+$196M
4
CMCSA icon
Comcast
CMCSA
+$165M
5
GSK icon
GSK
GSK
+$149M

Sector Composition

Rank Sector Weight
1 Technology 20.45%
2 Energy 18.88%
3 Healthcare 17.92%
4 Financials 10.19%
5 Consumer Staples 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFFN icon
926
Capitol Federal Financial
CFFN
$1.1B
$162K ﹤0.01%
+13,294
New +$162K
ISLE
927
DELISTED
Isle of Capri Casinos Inc
ISLE
$160K ﹤0.01%
18,741
CARB
928
DELISTED
Carbonite Inc
CARB
$156K ﹤0.01%
13,050
-1,522
-10% -$15.7K
LSAK icon
929
Lesaka Technologies
LSAK
$419M
$153K ﹤0.01%
13,479
-31,311
-70% -$324K
BPZ
930
DELISTED
BPZ RESOURCES INC COM STK
BPZ
$146K ﹤0.01%
+47,408
New +$138K
XXIA
931
DELISTED
Ixia
XXIA
$145K ﹤0.01%
12,727
-177,571
-93% -$2.17M
WIBC
932
DELISTED
WILSHIRE BANCORP INC
WIBC
$145K ﹤0.01%
+14,074
New +$146K
IMI
933
DELISTED
Intermolecular, Inc.
IMI
$138K ﹤0.01%
+59,382
New +$148K
OSUR icon
934
OraSure Technologies
OSUR
$275M
$134K ﹤0.01%
+15,556
New +$109K
PSMI
935
DELISTED
PEREGRINE SEMICONDUCTOR CORP COM STK (DE)
PSMI
$117K ﹤0.01%
+17,113
New +$107K
MWA icon
936
Mueller Water Products
MWA
$4.18B
$90K ﹤0.01%
+10,469
New +$92.7K
OIBR.C
937
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$88K ﹤0.01%
181
+159
+723% +$84.8K
MRGE
938
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
$76K ﹤0.01%
+33,611
New +$76.5K
DENN
939
DELISTED
Denny's
DENN
$75K ﹤0.01%
11,450
-798,575
-99% -$5.21M
PSHG icon
940
Performance Shipping
PSHG
$21.8M
0
FRO icon
941
Frontline
FRO
$8.73B
$45K ﹤0.01%
+3,080
New +$46.9K
AA icon
942
Alcoa
AA
$13.2B
-179,337
Closed -$5.55M
A icon
943
Agilent Technologies
A
$40.8B
-69,260
Closed -$2.77M
ABEV icon
944
Ambev
ABEV
$46.7B
-239,889
Closed -$1.78M
ABT icon
945
Abbott
ABT
$186B
-42,005
Closed -$1.62M
ACLS icon
946
Axcelis
ACLS
$4.28B
-15,030
Closed -$129K
ADM icon
947
Archer Daniels Midland
ADM
$37.3B
-3,128,050
Closed -$136M
AEIS icon
948
Advanced Energy
AEIS
$13.1B
-31,343
Closed -$768K
AFG icon
949
American Financial Group
AFG
$12.1B
-61,265
Closed -$3.54M
AGI icon
950
Alamos Gold
AGI
$13.9B
-59,383
Closed -$537K

Similar funds

Arrowstreet Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.

  • Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
  • Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
  • Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
  • Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
  • Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
  • Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
  • Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.

Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.